Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients

@inproceedings{Izquierdo2012ParicalcitolRO,
  title={Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients},
  author={Mar{\'i}a Jes{\'u}s Izquierdo and M{\'o}nica Cavia and Pilar Mu{\~n}iz and Angel L. M. de Francisco and Manuel A Arias and Javier Santos and Pedro Abaigar},
  booktitle={BMC nephrology},
  year={2012}
}
BACKGROUND Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and independently of parathyroid hormone (PTH) levels. The objective of this study was to evaluate the additional antioxidant capacity of paricalcitol in a clinical setting. METHODS The study included 19 patients with renal disease on hemodialysis, of whom peripheral blood was… CONTINUE READING
22 Citations
54 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Oral Paricalcitol improves inflammatory profile in Haemodialysis Patients

  • J Juan Navarro-González, ML Méndez, C Mora, J Donate, J García
  • Abstract SU424. World Congress of Nephrology…
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…